BTG’s varicose-vein drug successful in U.S. study
by on Jan.30, 2012, under Health and Fitness
LONDON (Reuters) – British pharmaceutical firm BTG said the first of two U.S. trials of its varicose vein treatment Varisolve had met all its end-points, bringing a launch of the long-delayed product a step closer. Varisolve is a ground-breaking t…
View full post on Yahoo! Health News
